Skandinaviska Enskilda Banken (SEB)
SGMO

Skandinaviska Enskilda Banken (SEB)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34,000
Closed -$426K – 1130
2021
Q1 		$426K Sell
34,000
-15,600
-31% -$210K ﹤0.01% 954
2020
Q4 		$774K Hold
49,600
– – 0.01% 858
2020
Q3 		$469K Buy
+49,600
New +$536K ﹤0.01% 836

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s SGMO Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 34,000 shares — an estimated $426K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SGMO in Q3 2020 and held it in 3 quarters. The position peaked at $774K in Q4 2020. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 34,000 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $426K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s SANGAMO THERAPEUTICS INC position peaked at $774K in Q4 2020.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.